Primary Site >> Biliary tract Cancer

Gene >> CD274

Journal: J Surg Oncol. 2009 Nov 1;100(6):500-4.
Title: Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion.
Author: Ye, Yufu|Zhou, Lin|Xie, Xiaojun|Jiang, Guoping|Xie, Haiyang|Zheng, Shusen
PMID: 19697355
Journal: Cancer Sci. 2014 Jun;105(6):667-74.
Title: Suppressive expression of CD274 increases tumorigenesis and cancer stem cell phenotypes in cholangiocarcinoma.
Author: Tamai, Keiichi|Nakamura, Mao|Mizuma, Masamichi|Mochizuki, Mai|Yokoyama, Misa|Endo, Hiroyuki|Yamaguchi, Kazunori|Nakagawa, Takayuki|Shiina, Masaaki|Unno, Michiaki|Muramoto, Koji|Sato, Ikuro|Satoh, Kennichi|Sugamura, Kazuo|Tanaka, Nobuyuki
PMID: 24673799
Journal: Anticancer Res. 2014 Nov;34(11):6353-61.
Title: Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy.
Author: Koido, Shigeo|Kan, Shin|Yoshida, Kosaku|Yoshizaki, Shinji|Takakura, Kazuki|Namiki, Yoshihisa|Tsukinaga, Shintaro|Odahara, Shunichi|Kajihara, Mikio|Okamoto, Masato|Ito, Masaki|Yusa, Sei-Ichi|Gong, Jianlin|Sugiyama, Haruo|Ohkusa, Toshifumi|Homma, Sadamu|Taj
PMID: 25368235
Journal: Radiother Oncol. 2015 Oct;117(1):165-70.
Title: High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy.
Author: Lim, Yu Jin|Koh, Jaemoon|Kim, Kyubo|Chie, Eui Kyu|Kim, BoKyong|Lee, Kyoung Bun|Jang, Jin-Young|Kim, Sun-Whe|Oh, Do-Youn|Bang, Yung-Jue|Ha, Sung W
PMID: 26235847
Journal: Clin Cancer Res. 2016 Jan 15;22(2):470-8.
Title: PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma.
Author: Sabbatino, Francesco|Villani, Vincenzo|Yearley, Jennifer H|Deshpande, Vikram|Cai, Lei|Konstantinidis, Ioannis T|Moon, Christina|Nota, Sjoerd|Wang, Yangyang|Al-Sukaini, Ahmad|Zhu, Andrew X|Goyal, Lipika|Ting, David T|Bardeesy, Nabeel|Hong, Theodore S|Ferna
PMID: 26373575
Journal: Ann Surg Oncol. 2016 Aug;23(8):2610-7.
Title: Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma.
Author: Gani, Faiz|Nagarajan, Neeraja|Kim, Yuhree|Zhu, Qingfeng|Luan, Lan|Bhaijjee, Feriyl|Anders, Robert A|Pawlik, Timothy M
PMID: 27012989
Journal: Oncotarget. 2016 Oct 25;7(43):69749-69759.
Title: Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma.
Author: Wang, Lei|Dong, Hui|Ni, Shujuan|Huang, Dan|Tan, Cong|Chang, Bin|Sheng, Weiqi
PMID: 27626174
Journal: Oncotarget. 2016 Nov 22;7(47):76604-76612.
Title: Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy.
Author: Ha, Hyerim|Nam, Ah-Rong|Bang, Ju-Hee|Park, Ji-Eun|Kim, Tae-Yong|Lee, Kyung-Hun|Han, Sae-Won|Im, Seock-Ah|Kim, Tae-You|Bang, Yung-Jue|Oh, Do-Youn
PMID: 27780932
Journal: Histopathology. 2017 Sep;71(3):470-474.
Title: PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions.
Author: Saraggi, Deborah|Galuppini, Francesca|Remo, Andrea|Urso, Emanuele D L|Bacchin, Deborah|Salmaso, Roberta|Lanza, Cristiano|Bao, Riccardo Q|Fanelli, Giuseppe N|Guzzardo, Vincenza|Luchini, Claudio|Scarpa, Marco|Farinati, Fabio|Fassan, Matteo|Rugge, Massimo
PMID: 28502094
Journal: Oncol Lett. 2017 Jul;14(1):250-256.
Title: PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma.
Author: Ma, Ke|Wei, Xin|Dong, Danfeng|Wu, Yinying|Geng, Qianqian|Li, Enxiao
PMID: 28693161
Journal: Asian Pac J Cancer Prev. 2017 Jun 25;18(6):1671-1674.
Title: Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma
Author: Sangkhamanon, Sakkarn|Jongpairat, Piangpen|Sookprasert, Aumkhae|Wirasorn, Kosin|Titapun, Attapol|Pugkhem, Ake|Ungareevittaya, Piti|Chindaprasirt, Jarin
PMID: 28670887
Journal: Cold Spring Harb Mol Case Stud. 2017 Sep 1;3(5). pii: mcs.a001974.
Title: Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer.
Author: Czink, Elena|Kloor, Matthias|Goeppert, Benjamin|Frohling, Stefan|Uhrig, Sebastian|Weber, Tim F|Meinel, Jorn|Sutter, Christian|Weiss, Karl Heinz|Schirmacher, Peter|Doeberitz, Magnus von Knebel|Jager, Dirk|Springfeld, Christoph
PMID: 28619747
Journal: Int J Cancer. 2017 Aug 1;141(3):572-582.
Title: Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer.
Author: Sideras, Kostandinos|Biermann, Katharina|Yap, Kevin|Mancham, Shanta|Boor, Patrick P C|Hansen, Bettina E|Stoop, Hans J A|Peppelenbosch, Maikel P|van Eijck, Casper H|Sleijfer, Stefan|Kwekkeboom, Jaap|Bruno, Marco J
PMID: 28470686
Journal: Oncotarget. 2017 Apr 11;8(15):24644-24651.
Title: PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma.
Author: Fontugne, Jacqueline|Augustin, Jeremy|Pujals, Anais|Compagnon, Philippe|Rousseau, Benoit|Luciani, Alain|Tournigand, Christophe|Cherqui, Daniel|Azoulay, Daniel|Pawlotsky, Jean-Michel|Calderaro, Julien
PMID: 28445951
Journal: Histopathology. 2017 Sep;71(3):383-392.
Title: PD-L1 expression in extrahepatic cholangiocarcinoma.
Author: Walter, Dirk|Herrmann, Eva|Schnitzbauer, Andreas A|Zeuzem, Stefan|Hansmann, Martin Leo|Peveling-Oberhag, Jan|Hartmann, Sylvia
PMID: 28419539
Journal: Pathol Int. 2017 Mar;67(3):163-170.
Title: The PD-1/PD-L1 axis may be aberrantly activated in occupational cholangiocarcinoma.
Author: Sato, Yasunori|Kinoshita, Masahiko|Takemura, Shigekazu|Tanaka, Shogo|Hamano, Genya|Nakamori, Shoji|Fujikawa, Masahiro|Sugawara, Yasuhiko|Yamamoto, Takatsugu|Arimoto, Akira|Yamamura, Minako|Sasaki, Motoko|Harada, Kenichi|Nakanuma, Yasuni|Kubo, Shoji
PMID: 28139862
Journal: Oncotarget. 2018 Apr 13;9(28):20034-20047.
Title: Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma.
Author: Ueno, Takashi|Tsuchikawa, Takahiro|Hatanaka, Kanako C|Hatanaka, Yutaka|Mitsuhashi, Tomoko|Nakanishi, Yoshitsugu|Noji, Takehiro|Nakamura, Toru|Okamura, Keisuke|Matsuno, Yoshihiro|Hirano, Satoshi
PMID: 29732001
Journal: Oncotarget. 2018 May 4;9(34):23366-23372.
Title: Prognostic value of CD8CD45RO tumor infiltrating lymphocytes in patients with extrahepatic cholangiocarcinoma.
Author: Kim, Richard|Coppola, Domenico|Wang, Emilie|Chang, Young Doo|Kim, Yuhree|Anaya, Daniel|Kim, Dae Won
PMID: 29805739
Journal: Histopathology. 2018 Oct;73(4):622-633.
Title: Clinical relevance of PD-L1 expression in gallbladder cancer: a potential target for therapy.
Author: Neyaz, Azfar|Husain, Nuzhat|Kumari, Swati|Gupta, Sameer|Shukla, Saumya|Arshad, Sanya|Anand, Nidhi|Chaturvedi, Arun
PMID: 29882997
Journal: Jpn J Clin Oncol. 2018 Aug 1;48(8):703-711.
Title: New developments in systemic therapy for advanced biliary tract cancer.
Author: Morizane, Chigusa|Ueno, Makoto|Ikeda, Masafumi|Okusaka, Takuji|Ishii, Hiroshi|Furuse, Junji
PMID: 29893894
Journal: Gut. 2018 Jun 28. pii: gutjnl-2018-316039.
Title: Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.
Author: Li, Maolan|Liu, Fatao|Zhang, Fei|Zhou, Weiping|Jiang, Xiaoqing|Yang, Yuan|Qu, Kai|Wang, Yueqi|Ma, Qiang|Wang, Ting|Bai, Lu|Wang, Zheng|Song, Xiaoling|Zhu, Yidi|Yuan, Ruiyan|Gao, Yuan|Liu, Yongchen|Jin, Yunpeng|Li, Huaifeng|Xiang, Shanshan|Ye, Yuanyuan|Zha
PMID: 29954840
Journal: BMC Cancer. 2018 Jul 28;18(1):766.
Title: Classification of gallbladder cancer by assessment of CD8(+) TIL and PD-L1 expression.
Author: Lin, Jianzhen|Long, Junyu|Wan, Xueshuai|Chen, Jingci|Bai, Yi|Wang, Anqiang|Yang, Xiaobo|Wu, Yan|Robson, Simon C|Sang, Xinting|Zhao, Haitao
PMID: 30055582
Journal: Cancer Manag Res. 2018 Oct 2;10:4113-4123.
Title: Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8(+) T-cell immune responses.
Author: Zhu, Ying|Wang, Xiang-Yu|Zhang, Yu|Xu, Da|Dong, Jian|Zhang, Ze|Yi, Chen-He|Jia, Hu-Liang|Yang, Xin
PMID: 30323667
Journal: Br J Cancer. 2018 Oct 31. pii: 10.1038/s41416-018-0199-2.
Title: Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma.
Author: Goeppert, Benjamin|Roessler, Stephanie|Renner, Marcus|Singer, Stephan|Mehrabi, Arianeb|Vogel, Monika Nadja|Pathil, Anita|Czink, Elena|Kohler, Bruno|Springfeld, Christoph|Pfeiffenberger, Jan|Rupp, Christian|Weiss, Karl Heinz|Schirmacher, Peter|von Knebel D
PMID: 30377340